Covid Might Cure Cancer. No, You Didn’t Read That Wrong; Can COVID-19 Help the Body Fight Cancer? Shocking New Study Links Virus to Shrinking Tumors, and other C-Virus related stories
Covid might cure cancer. No, you didn’t read that wrong:
Illinois researchers have found an unbelievable link between infection with Covid and cancer regression where tumors decrease in size or extent.
Using animals and tissue from humans, scientists observed that the RNA molecules of the SARS-CoV-2 virus, which is responsible for the disease, triggered the development of a special cell in the immune system that has anti-cancer properties.
Known as “inducible nonclassical monocytes” or “I-NCMs,” these special cells attack cancer cells and could be used to treat cancers that are resistant to current therapies, according to Northwestern Medicine Canning Thoracic Institute scientists.
“This discovery opens up a new avenue for cancer treatment,” Dr. Ankit Bharat, the Canning Thoracic Institute’s chief of thoracic surgery, said.. “We found that the same cells activated by severe Covid-19 could be induced with a drug to fight cancer, and we specifically saw a response with melanoma, lung, breast and colon cancer in the study.”
Bharat was the senior author of the findings published last week in the The Journal of Clinical Investigation. The study was funded by the National Institutes of Health.
He said that while the research was still in the early stages, with effectiveness only studied in animals, it “offers hope that we might be able to use this approach to benefit patients with advanced cancers that have not responded to other treatments.” —>READ MORE HERE
Can COVID-19 help the body fight cancer? Shocking new study links virus to shrinking tumors:
Scientists have discovered a surprising silver lining of COVID-19 infection.
A new study by researchers at Northwestern Medicine Canning Thoracic Institute, published in the Journal of Clinical Investigation, revealed a correlation between COVID-19 infection and cancer regression.
Though doctors at Northwestern University warned that the research is still in early stages, they’re hopeful that more tests could lead to new treatments in the future.
The team observed that the RNA from the SARS-CoV-2 virus can trigger the development of anti-cancer immune cells.
Called “inducible nonclassical monocytes (I-NCMs),” these immune cells showed the potential to attack cancer cells, opening up new possibilities for treatment. Rare compared to other types of monocytes, I-NCMs multiply when inflammation materializes, as it does during COVID-19 infection.
“We found that the same cells activated by severe COVID-19 could be induced with a drug to fight cancer, and we specifically saw a response with melanoma, lung, breast and colon cancer in the study,” said study author Ankit Bharat, MD, chief of thoracic surgery and director of the Canning Thoracic Institute.
“While this is still in the early stages and the effectiveness was only studied in preclinical animal models, it offers hope that we might be able to use this approach to benefit patients with advanced cancers that have not responded to other treatments.” —>READ MORE HERE
Follow links below to relevant/related stories and resources:
Pediatric hospital beds lost due to impact of COVID-19 pandemic
Covid Can Raise the Risk of Heart Problems for Years
USA TODAY: Coronavirus Updates
YAHOO NEWS: Coronavirus Live Updates
NEW YORK POST: Coronavirus The Latest
If you like what you see, please “Like” and/or Follow us on FACEBOOK here, GETTR here, and TWITTER here.
Jesus Christ is King
Comments are closed.